Screener
Opus Genetics IRD Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Opus Genetics in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The source filing: Opus Genetics’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 4:03 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-034084
| Assets | As of / March 31,2026 / (Unaudited) | As of / December 31,2025 |
|---|---|---|
| Current liabilities: | ||
| Accounts payable | $4,422 | $3,293 |
| Accrued expenses | 4,918 | 4,488 |
| Total current liabilities | 9,340 | 7,781 |
| Warrant liabilities | 77,349 | 25,985 |
| Funding agreement, related party | 1,198 | 1,129 |
| Total liabilities | 87,887 | 34,895 |
| Commitments and contingencies (Note 3 and Note 9) |
Item 1. Financial Statements
FAQ
- What is Opus Genetics's total current liabilities?
- Opus Genetics (IRD) reported total current liabilities of $9.34M in Q1 2026.
- How has Opus Genetics's total current liabilities changed year-over-year?
- Opus Genetics's total current liabilities decreased by 61.5% year-over-year, from $24.25M to $9.34M.
- What is the long-term trend for Opus Genetics's total current liabilities?
- Over 5 years (2020 to 2025), Opus Genetics's total current liabilities has grown at a 19.6% compound annual growth rate (CAGR), from $3.19M to $7.78M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.
Ask your AI about Opus Genetics's total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude